Gingival Hyperplasia: A Collateral Damage Due To Various Drugs
Tanvi Kalirawana
DOI:
https://doi.org/10.47611/jsrhs.v13i3.7268Keywords:
Gingival Hyperplasia, Cytokines, Immunosupression, Anti-hypertensiveAbstract
Gingival hyperplasia or gingival enlargement is abnormal overgrowth of gingiva around the teeth, arising most likely as a side effect of conventional medications for controlling seizures, high blood pressure, immunosuppressants often referred as Drug Induced Gingival Hyperplasia (DIGH). It causes swelling, bleeding, difficulty with chewing and pronunciation. Long-term use of these drugs has been linked to overexpression of several chemokines and interleukins, causing gingival overgrowth as an aftereffect. It is still largely unknown how the fibroblasts proliferate during the period of drug administration and what kind of morphological changes occur when the drug accumulates in the cell cytoplasm. This paper reviews the current literature surrounding the various drugs and their impact on gingival enlargement that in turn affects the oral hygiene of patients receiving the medications and ways to rectify the damage.
Downloads
References or Bibliography
References
(1) Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc. 1998 Dec;73(12):1196-9. doi: 10.4065/73.12.1196. PMID: 9868421.
(2Tungare S, Paranjpe AG. Drug-Induced Gingival Overgrowth. 2022 Sep 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30860753.
(3) Desai P, Silver JG. Drug-induced gingival enlargements. J Can Dent Assoc. 1998 Apr;64(4):263-8. PMID: 9594464.
(4) Goriuc A, Foia LG, Minea B, Luchian AI, Surdu AE, Toma V, Costuleanu M, Mârţu I. Drug-induced gingival hyperplasia - experimental model. Rom J Morphol Embryol. 2017;58(4):1371-1376. PMID: 29556630.
(5) Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000 Apr;117(4):1162-72. doi: 10.1378/chest.117.4.1162. PMID: 10767254.
(6) Tayal V, Kalra BS. Cytokines and anti-cytokines as therapeutics--an update. Eur J Pharmacol. 2008 Jan 28;579(1-3):1-12. doi: 10.1016/j.ejphar.2007.10.049. Epub 2007 Oct 25. PMID: 18021769.
(6) Tayal V, Kalra BS. Cytokines and anti-cytokines as therapeutics--an update. Eur J Pharmacol. 2008 Jan 28;579(1-3):1-12. doi: 10.1016/j.ejphar.2007.10.049. Epub 2007 Oct 25. PMID: 18021769.
(7) Catibusic FH, Uzicanin S, Salihbegovic EV, Huseinbegovic Z. Efficacy and Safety of Levetiracetam for Childhood Epilepsies. Med Arch. 2024;78(2):122-126. doi: 10.5455/medarh.2024.78.122-126. PMID: 38566869; PMCID: PMC10983095.
(8) James J, Jose J, Gafoor VA. Levetiracetam-induced gingival hyperplasia. J Postgrad Med. 2022 Jul-Sep;68(3):168-169. doi: 10.4103/jpgm.jpgm_1059_21. PMID: 35848684; PMCID: PMC9733520.
(9) Merritt HH, Putnam TJ. Landmark article Sept 17, 1938: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. By H. Houston Merritt and Tracy J. Putnam. JAMA. 1984 Feb 24;251(8):1062-7. doi: 10.1001/jama.251.8.1062. PMID: 6363736.
(10) Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol. 1972 Dec;34(6):898-906. doi: 10.1016/0030-4220(72)90228-9. PMID: 4509004.
(11) Arya R, Gulati S, Kabra M, Sahu JK, Kalra V. Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children. Neurology. 2011 Apr 12;76(15):1338-43. doi: 10.1212/WNL.0b013e3182152844. PMID: 21482950; PMCID: PMC3090066.
(12) Namikawa K, Maruo T, Honda M, Hirata H, Lynch J, Madarame H. Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia. Can Vet J. 2012 Jan;53(1):67-70. PMID: 22753966; PMCID: PMC3239152.
(13) Lauritano D, Palmieri A, Lucchese A, Di Stasio D, Moreo G, Carinci F. Role of Cyclosporine in Gingival Hyperplasia: An In Vitro Study on Gingival Fibroblasts. Int J Mol Sci. 2020 Jan 16;21(2):595. doi: 10.3390/ijms21020595. PMID: 31963361; PMCID: PMC7014429.
(14) Seymour RA, Ellis JS, Thomason JM, Monkman S, Idle JR. Amlodipine-induced gingival overgrowth. J Clin Periodontol. 1994 Apr;21(4):281-3. doi: 10.1111/j.1600-051x.1994.tb00318.x. PMID: 8195445.
(15) Lafzi A, Farahani RM, Shoja MA. Amlodipine-induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal. 2006 Nov 1;11(6):E480-2. PMID: 17072250.
(16) Lawrence DB, Weart CW, Laro JJ, Neville BW. Calcium channel blocker-induced gingival hyperplasia: case report and review of this iatrogenic disease. J Fam Pract. 1994 Nov;39(5):483-8. PMID: 7964547.
(17) Hall EE. Prevention and treatment considerations in patients with drug-induced gingival enlargement. Curr Opin Periodontol. 1997;4:59-63. PMID: 9655022.
(18) Pilloni A, Camargo PM, Carere M, Carranza FA Jr. Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: gingivectomy versus periodontal flap. J Periodontol. 1998 Jul;69(7):791-7. doi: 10.1902/jop.1998.69.7.791. PMID: 9706857.
(19) Orozco J, Rico D, Barrios L, Hoyos V, Blanco P. Histological artifacts associated with laser and electroscalpel gingivectomy: Case series. Biomedica. 2023 Sep 30;43(3):315-322. doi: 10.7705/biomedica.6930. PMID: 37871565; PMCID: PMC10617660.
(20) Ibrahim AH, Merzouk N, Abdelkoui A. Prosthetic and surgical management of a sizeable epulis fissuratum: a case report. Pan Afr Med J. 2022 Jan 18;41:49. doi: 10.11604/pamj.2022.41.49.31339. PMID: 35317487; PMCID: PMC8917454.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Tanvi Kalirawana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
